Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure

Launched by CHUNLING JIANG · Apr 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how having surgery to remove the parathyroid glands affects the quality of life for patients with secondary hyperparathyroidism due to end-stage renal failure. The goal is to understand if this surgery can help improve daily living and well-being for those who undergo it.

To participate in this study, individuals must be at least 18 years old and scheduled for this surgery related to their kidney condition. The trial is open to all genders. If you or a family member are considering this surgery, participating in the trial could provide valuable insights into how it may improve life after the procedure. It's important to note that this study is not yet recruiting participants, so there may be some time before it begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: ≥18 years old;
• • Patients scheduled for parathyroidectomy with secondary hyperparathyroidism due to end-stage renal failure
• Exclusion Criteria:
• • • Patients refuse to participate